For the quarter ending 2025-09-30, HIMS had -$779,172K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income | 15,774 | 42,505 | 49,485 | 26,025 |
| Depreciation and amortization | 17,669 | 10,465 | 8,276 | 6,061 |
| Stock-based compensation | 40,172 | 35,726 | 24,858 | 24,349 |
| Change in fair value of liabilities | 7,626 | - | - | - |
| Net accretion on securities | 253 | 367 | 693 | 915 |
| Benefit from deferred taxes | 862 | -9,456 | -890 | -7,309 |
| Impairment of long-lived assets | 531 | 0 | - | 0 |
| Amortization of debt discount and issuance costs | 1,743 | 1,047 | - | - |
| Non-cash operating lease cost | -3,311 | -2,689 | -1,905 | -671 |
| Non-cash acquisition-related costs | 1,976 | 1,955 | 1,030 | 0 |
| Non-cash other | 814 | 2,147 | -832 | 78 |
| Inventory | -37,270 | 65,704 | 11,669 | 15,317 |
| Prepaid expenses and other current assets | 16,301 | 20,842 | 17,239 | 7,959 |
| Other long-term assets | -5 | 83 | -73 | 9 |
| Accounts payable | 70,952 | -9,327 | 14,473 | 8,658 |
| Accrued liabilities | -52,883 | 7,386 | 4,351 | 9,789 |
| Deferred revenue | 19,947 | -12,348 | 35,480 | 43,101 |
| Operating lease liabilities | 1,134 | -616 | -1,182 | -682 |
| Earn-out payable | 0 | 0 | - | 0 |
| Net cash provided by operating activities | 148,721 | -19,117 | 109,090 | 86,385 |
| Purchases of investments | 713,556 | 0 | 0 | 9,969 |
| Maturities of investments | 12,188 | 29,227 | 31,342 | 19,648 |
| Proceeds from sales of investments | 0 | - | - | 0 |
| Investment in website development and internal-use software | 4,092 | 4,250 | 3,711 | 2,365 |
| Purchases of property, equipment, and intangible assets | 65,265 | 46,065 | 55,327 | 24,520 |
| Acquisition of businesses, net of cash acquired | 116,673 | 0 | 5,100 | 0 |
| Deferred consideration paid for acquisitions | - | - | - | 0 |
| Net cash used in investing activities | -887,398 | -21,088 | -32,796 | -17,206 |
| Proceeds from issuance of convertible senior notes, net of debt discount | 0 | 970,000 | - | - |
| Purchases of capped calls related to convertible senior notes | 0 | -47,800 | - | - |
| Proceeds from exercise of vested stock options | 3,299 | 2,569 | -14,577 | 26,651 |
| Payments for taxes related to net share settlement of equity awards | 32,480 | 36,764 | 25,711 | 19,405 |
| Proceeds from employee stock purchase plan | 0 | 2,970 | - | 2,279 |
| Payments for debt issuance costs | 349 | 1,806 | 1,235 | - |
| Repurchases of common stock | 9,479 | 0 | 0 | 5,005 |
| Proceeds from exercise of class a common stock warrants | - | - | - | 333 |
| Payments for acquisition-related earn-out consideration | 0 | 0 | - | 0 |
| Net cash provided by (used in) financing activities | -39,009 | 889,169 | -23,018 | -13,652 |
| Foreign currency effect on cash and cash equivalents | -1,486 | 1,027 | 243 | -461 |
| Increase in cash, cash equivalents, and restricted cash | -779,172 | 849,991 | 53,519 | 55,066 |
| Cash and cash equivalents at beginning of period | 1,124,950 | 274,959 | 221,440 | 166,374 |
| Cash and cash equivalents at end of period | 345,778 | 1,124,950 | 274,959 | 221,440 |
Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (HIMS)